title: Postoperative care of the transplanted patient.
abstract: The successful delivery of optimal peri-operative care to pediatric heart transplant recipients is a vital determinant of their overall outcomes. The practitioner caring for these patients must be familiar with and treat multiple simultaneous issues in a patient who may have been critically ill preoperatively. In addition to the complexities involved in treating any child following cardiac surgery, caretakers of newly transplanted patients encounter multiple transplant-specific issues. This chapter details peri-operative management strategies, frequently encountered early morbidities, initiation of immunosuppression including induction, and short-term outcomes.
authors.affiliation: University of Michigan Congenital Heart Center, Michigan, USA. kurts@med.umich.edu
authors.forename: Kurt R
authors.initials: KR
authors.lastname: Schumacher
authors.forename: Robert J
authors.initials: RJ
authors.lastname: Gajarski
mesh_terms: D001424:Bacterial Infections / Q000628:therapy; D003422:Critical Care / Q000379:methods; D003586:Cytomegalovirus Infections / Q000628:therapy; D015199:Extracorporeal Membrane Oxygenation / Q000379:methods; D006084:Graft Rejection / Q000276:immunology / Q000628:therapy; D006680:HLA Antigens / Q000276:immunology; D016027:Heart Transplantation / Q000009:adverse effects / Q000276:immunology; D006439:Hemodynamics / Q000502:physiology; D006648:Histocompatibility; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011182:Postoperative Care / Q000379:methods*; D011183:Postoperative Complications / Q000628:therapy*; D014655:Vascular Resistance / Q000502:physiology
chemical_list: D006680:HLA Antigens; D007166:Immunosuppressive Agents